Trial
NCT03031821
Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Canadian Urologic Oncology Group
Collaborators
Prostate Cancer Canada; British Columbia Cancer Agency; BC Cancer Foundation
Condition
Prostate Cancer
Intervention
Metformin
Why stopped
Manufacturer discontinued the production of study drugs.
Provenance
Dataset: 2026-07-31 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-29